Law360, New York (September 11, 2009) -- The judge in charge of the first trial over Merck & Co. Inc.'s osteoporosis drug Fosamax declared a mistrial Friday after the jury told the court it was hopelessly deadlocked and could not reach a unanimous verdict.
The mistrial came two days after Judge John Keenan of the U.S. District Court for the Southern District of New York ordered a daylong break from deliberations as reports emerged...
